Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3-Hydroxybutyric acid sodium (β-Hydroxybutyric acid sodium) is a metabolite present in type I diabetic patients that has the property of regulating membrane lipids.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 mg | In stock | $ 41.00 | |
1 g | In stock | $ 58.00 |
Description | 3-Hydroxybutyric acid sodium (β-Hydroxybutyric acid sodium) is a metabolite present in type I diabetic patients that has the property of regulating membrane lipids. |
In vitro | The 3-Hydroxybutyric acid medium can interact with lipids (using DPPC monolayer modeling) and alter phase behavior at clinical concentrations. The 3-Hydroxybutyric acid solid also reduces the interfacial viscosity of the DPPC monolayer.[1] |
Synonyms | β-Hydroxybutyric acid sodium |
Molecular Weight | 126.09 |
Formula | C4H7NaO3 |
CAS No. | 150-83-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 22.5 mg/mL (178.4 mM ), Sonication and heating to 60℃ are recommended.
DMSO: 60 mg/mL (472.11 mM), Sonication and heating to 60℃ are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3-Hydroxybutyric acid sodium 150-83-4 β-Hydroxybutyric acid sodium beta-Hydroxybutyric acid sodium b-Hydroxybutyric acid sodium inhibitor inhibit